
Contributed to the mrc-ide/malariasimulation repository by developing and refining drug parameterization and malaria modeling workflows, with a focus on P. falciparum and P. vivax. Enhanced drug efficacy simulation by standardizing parameter handling, implementing parasite-specific validation, and improving test coverage for liver-stage prophylaxis. Addressed bugs in PMC age subsetting and timestep logic, aligning implementation with epidemiological patterns. Improved documentation for both drug and mosquito parameters, supporting reproducibility and traceability. Leveraged R and R Markdown for software development, statistical modeling, and technical writing, delivering features that strengthened model accuracy, error handling, and maintainability across evolving simulation requirements.
January 2025 monthly summary for mrc-ide/malariasimulation focusing on delivering vivax-focused outputs, improving parasite-type validation, and enhancing documentation for traceability. The work delivered two main features with targeted bug fixes, delivering clearer vivax reporting, improved error handling, and better maintainability. The period also reinforced business value by enabling more accurate vivax analyses and reproducibility across parameter configurations.
January 2025 monthly summary for mrc-ide/malariasimulation focusing on delivering vivax-focused outputs, improving parasite-type validation, and enhancing documentation for traceability. The work delivered two main features with targeted bug fixes, delivering clearer vivax reporting, improved error handling, and better maintainability. The period also reinforced business value by enabling more accurate vivax analyses and reproducibility across parameter configurations.
December 2024 monthly summary for mrc-ide/malariasimulation focusing on key features delivered, bugs fixed, and overall impact. Emphasizes business value of accurate drug efficacy modeling for P. vivax and robust PMC time-step logic, with clear release-readiness.
December 2024 monthly summary for mrc-ide/malariasimulation focusing on key features delivered, bugs fixed, and overall impact. Emphasizes business value of accurate drug efficacy modeling for P. vivax and robust PMC time-step logic, with clear release-readiness.
November 2024 monthly summary for mrc-ide/malariasimulation. Focused on enhancing P. vivax modeling through parameter integration and documentation, and a targeted cleanup of liver-stage prophylaxis logic to improve accuracy and test reliability. These changes strengthen model fidelity, reproducibility, and documentation for stakeholders.
November 2024 monthly summary for mrc-ide/malariasimulation. Focused on enhancing P. vivax modeling through parameter integration and documentation, and a targeted cleanup of liver-stage prophylaxis logic to improve accuracy and test reliability. These changes strengthen model fidelity, reproducibility, and documentation for stakeholders.
October 2024 monthly summary for the mrc-ide/malariasimulation repository focused on delivering a robust, backward-compatible drug parameter handling workflow for P. falciparum. Implemented drug naming standardization and parasite-specific parameter validation warnings within the drug setup flow, accompanied by tests for liver stage prophylaxis calculations. This work reduces parameter attribution errors, improves modeling reliability, and supports reproducible research workflows.
October 2024 monthly summary for the mrc-ide/malariasimulation repository focused on delivering a robust, backward-compatible drug parameter handling workflow for P. falciparum. Implemented drug naming standardization and parasite-specific parameter validation warnings within the drug setup flow, accompanied by tests for liver stage prophylaxis calculations. This work reduces parameter attribution errors, improves modeling reliability, and supports reproducible research workflows.

Overview of all repositories you've contributed to across your timeline